Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Conference Conversations: HIV Pharmacist Perspectives from CROI 2022

Source: Conference Coverage of CROI 2022: Clinical Impact of New HIV Data*
February 13-16, 2022; Virtual
Listen to expert insights from Fidelia Bernice, PharmD, and Jennifer Cocohoba, PharmD, as they discuss new data presented at CROI 2022, including key findings on investigational options for PrEP, interactions between hormone therapy and PrEP in transgender individuals, impact of anticholinergic drug effects on older PWH, and medication adherence in PWH.
Fidelia Bernice, PharmD
Jennifer Cocohoba Headshot
Jennifer Cocohoba, PharmD
Released: March 15, 2022

In this episode, Fidelia Bernice, PharmD, and Jennifer Cocohoba, PharmD, share insights on new HIV data from CROI 2022, including:

  • Islatravir tissue and plasma distribution after monthly oral dosing
  • Pharmacokinetics, safety, and acceptability of a tenofovir vaginal ring
  • PrEP and Hormone Therapy in Transgender Individuals
  • Anticholinergic drug effects in older PWH
  • Adherence in PWH

Information on this Educational Activity

Faculty

Fidelia Bernice, PharmD

Clinical Pharmacy Specialist, Infectious Diseases
Department of Pharmacy
University of Maryland Medical Center
Baltimore, Maryland

Fidelia Bernice, PharmD, has no relevant conflicts of interest to report.
Jennifer Cocohoba, PharmD

Professor
Department of Clinical Pharmacy
University of California, San Francisco
Pharmacist
Women's HIV Program
University of California San Francisco Medical Center
San Francisco, California

Jennifer Cocohoba, PharmD, has disclosed that she has received funds for research support from ViiV and educational contracts for university fellowship programs from Genentech and Janssen.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Cepheid
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck & Co., Inc.
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings